Toll-like receptor ligands as adjuvants in allergen-specific immunotherapy.
about
Unlipidated outer membrane protein Omp16 (U-Omp16) from Brucella spp. as nasal adjuvant induces a Th1 immune response and modulates the Th2 allergic response to cow's milk proteinsTranslational mini-review series on Toll-like receptors: Toll-like receptor ligands as novel pharmaceuticals for allergic disorders.Resiquimod and other immune response modifiers as vaccine adjuvants.Intralymphatic immunotherapy and vaccination in mice.A combination hydrogel microparticle-based vaccine prevents type 1 diabetes in non-obese diabetic mice.Agonists of Toll-like receptors 3, 4, 7, and 9 are candidates for use as adjuvants in an outer membrane vaccine against Neisseria meningitidis serogroup B.Toll-like receptors and leishmaniasis.Antigen kinetics determines immune reactivity.New routes for allergen immunotherapy.mRNA vaccination as a safe approach for specific protection from type I allergy.Adjuvants for allergy vaccinesNew directions in immunotherapy.Novel strategies for the treatment of grass pollen-induced allergic rhinitis.Medication with antihistamines impairs allergen-specific immunotherapy in mice.Prophylactic immunization of mice with phospholipase A2-loaded gas-filled microbubbles is protective against Th2-mediated honeybee venom allergy.Efficacy of a therapeutic treatment using gas-filled microbubble-associated phospholipase A2 in a mouse model of honeybee venom allergy.Microcrystalline Tyrosine and Aluminum as Adjuvants in Allergen-Specific Immunotherapy Protect from IgE-Mediated Reactivity in Mouse Models and Act Independently of Inflammasome and TLR Signaling.Microbial Delivery Vehicles for Allergens and Allergen-Derived Peptides in Immunotherapy of Allergic Diseases.Covalent Coupling of Vitamin D3 to the Major Cat Allergen Fel d 1 Improves the Effects of Allergen-Specific Immunotherapy in a Mouse Model for Cat Allergy
P2860
Q27311087-305AFBFE-01B8-475A-A056-A86EA41E3B47Q34602052-46A82300-DEA1-4FB8-AFC7-92385B6BBDC8Q34700325-5EF69A3A-3015-44E0-B395-7BB521F23947Q35389863-5D54A247-CFDD-4352-9D27-6630DBFDE89DQ35960520-703CA07D-6640-4518-9983-91C0CEBDEDC6Q36313996-0B9F5E69-61F0-4592-BD14-61B9619B7D65Q36483521-F2A605D8-30BC-4000-B784-483947E96011Q36516144-F68D1575-B9EC-4F22-AE6A-C6A13AE09A2DQ36864957-9A80DBA4-0C67-4917-B0B0-3C1D45DCFF4AQ37965722-20A3F695-DA5F-48B7-8E79-F7FD7B14D394Q38055323-69D76C68-24B1-45CD-8FF6-A5937D0CC93CQ38073718-CCC5353B-0684-4587-892B-785363D78EFEQ38857421-7BB4AAC2-30FB-4E58-BC54-DE061CA6C7FCQ40143896-F7353068-D1D9-4B6B-94C7-3C2EAFBA9A29Q41031692-4312B254-24AF-459C-B7B3-9851842A55EEQ51533953-963B0D98-460D-43F9-8DDD-D1881C05D076Q52625055-BF76FF41-7BCE-471F-96D8-B790D1698580Q55693712-7388B876-3797-4B75-9E61-BDC2018C9C14Q57266968-98F01152-F520-4BFC-AB8C-B3F2789A299A
P2860
Toll-like receptor ligands as adjuvants in allergen-specific immunotherapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Toll-like receptor ligands as adjuvants in allergen-specific immunotherapy.
@en
type
label
Toll-like receptor ligands as adjuvants in allergen-specific immunotherapy.
@en
prefLabel
Toll-like receptor ligands as adjuvants in allergen-specific immunotherapy.
@en
P2093
P2860
P1476
Toll-like receptor ligands as adjuvants in allergen-specific immunotherapy.
@en
P2093
B R von Beust
B Wüthrich
J M Martinez Gomez
P Johansen
T M Kündig
P2860
P304
P356
10.1111/J.1365-2222.2005.02384.X
P577
2005-12-01T00:00:00Z